A199800 Stock Overview
ToolGen Incorporated, a biotechnology company, focuses on the development of genome editing technology in South Korea.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
ToolGen Incorporated Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩68,200.00 |
52 Week High | ₩110,000.00 |
52 Week Low | ₩26,100.00 |
Beta | 1.91 |
1 Month Change | 35.32% |
3 Month Change | -2.85% |
1 Year Change | 43.58% |
3 Year Change | -34.17% |
5 Year Change | -28.51% |
Change since IPO | 39.18% |
Recent News & Updates
Recent updates
Shareholder Returns
A199800 | KR Biotechs | KR Market | |
---|---|---|---|
7D | -29.8% | 1.4% | 2.4% |
1Y | 43.6% | 21.6% | 12.2% |
Return vs Industry: A199800 exceeded the KR Biotechs industry which returned 21.6% over the past year.
Return vs Market: A199800 exceeded the KR Market which returned 12.2% over the past year.
Price Volatility
A199800 volatility | |
---|---|
A199800 Average Weekly Movement | 18.0% |
Biotechs Industry Average Movement | 8.0% |
Market Average Movement | 5.2% |
10% most volatile stocks in KR Market | 11.9% |
10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A199800's share price has been volatile over the past 3 months.
Volatility Over Time: A199800's weekly volatility (18%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1999 | 83 | Young Ho Kim | https://www.toolgen.com |
ToolGen Incorporated, a biotechnology company, focuses on the development of genome editing technology in South Korea. The company develops clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 gene scissors for gene editing in eukaryotic cells. It is involved in patent monetization, treatment, and seed businesses.
ToolGen Incorporated Fundamentals Summary
A199800 fundamental statistics | |
---|---|
Market cap | ₩540.67b |
Earnings (TTM) | -₩42.34b |
Revenue (TTM) | ₩1.10b |
490.0x
P/S Ratio-12.8x
P/E RatioIs A199800 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A199800 income statement (TTM) | |
---|---|
Revenue | ₩1.10b |
Cost of Revenue | ₩196.62m |
Gross Profit | ₩906.79m |
Other Expenses | ₩43.25b |
Earnings | -₩42.34b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -5.34k |
Gross Margin | 82.18% |
Net Profit Margin | -3,837.21% |
Debt/Equity Ratio | 0% |
How did A199800 perform over the long term?
See historical performance and comparison